QC
MURA

Quent Capital’s Mural Oncology MURA Stock Holding History

Quent Capital’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-55
Closed -$69 – 897
2025
Q1 		$69 Sell
55
-12
-18% -$44 ﹤0.01% 1309
2024
Q4 		$216 Buy
67
+12
+22% +$42 ﹤0.01% 1299
2024
Q3 		$168 Hold
55
– – ﹤0.01% 1334
2024
Q2 		$173 Hold
55
– – ﹤0.01% 1325
2024
Q1 		$269 Buy
+55
New +$267 ﹤0.01% 1327

Other funds holding MURA

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Quent Capital's MURA Position: Q2 2025 in Review

Quent Capital sold out of Mural Oncology (MURA) in Q2 2025, closing a stake of 55 shares — an estimated $69 sold.

Quent Capital first reported a position in MURA in Q1 2024 and held it in 5 quarters. The position peaked at $269 in Q1 2024. 66 funds tracked by Wall St. Rank hold MURA as of Q2 2025.

  • Quent Capital reported no remaining Mural Oncology position as of Q2 2025 after selling out during the quarter.
  • Quent Capital sold 55 Mural Oncology shares in Q2 2025, an estimated $69.
  • Quent Capital first reported a position in Mural Oncology in Q1 2024 and held it in 5 quarters.
  • Quent Capital's Mural Oncology position peaked at $269 in Q1 2024.
  • 66 funds tracked by Wall St. Rank held Mural Oncology as of Q2 2025.

Based on Quent Capital's 13F filing for Q2 2025, filed 21 Jul 2025.